|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.22 USD | -0.52% |
|
-6.04% | -3.21% |
EPS & Dividend: Harmony Biosciences Holdings, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.48 | 0.58 | 2.97 | 2.13 | 2.51 | 3.164 | 4.064 | 4.709 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 36.15 | 42.64 | 55.10 | 32.30 | 34.41 | 36.41 | 36.41 | 36.41 |
| Nbr of stocks (in thousands) | 56,889 | 58,472 | 59,318 | 58,572 | 57,031 | 57,596 | 57,596 | - |
| Announcement Date | 3/25/21 | 2/28/22 | 2/21/23 | 2/22/24 | 2/25/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Harmony Biosciences Holdings, Inc.
| 2026-03-02 | Q4 2025 Earnings Release (Projected) |
| 2026-05-04 | Q1 2026 Earnings Release (Projected) |
| 2026-08-10 | Q2 2026 Earnings Release (Projected) |
| 2026-11-02 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | 11.51x | 2.39x | 1.77x | |
| 0.57% | 0.64% | 45.13x | 34.45x | 14.96x | |
| 2.35% | 2.42% | 21.43x | 6.75x | 5.91x | |
| 3.02% | 3.15% | 73.45x | 686.24x | 7.21x | |
| 2.86% | 2.91% | 20.1x | 7.15x | 5.04x | |
| 1.72% | 1.81% | 28.37x | 6.38x | 5.33x | |
| 2.87% | 2.98% | 19.99x | 6.27x | 5.29x | |
| 2.91% | 2.96% | 14.21x | 5.11x | 4.66x | |
| 3.19% | 3.12% | 15.82x | 8.6x | 5.62x | |
| 2.9% | 3.04% | 25.81x | 19.64x | 6.12x | |
| Average | 2.24% | 2.3% | 27.58x | 78.30x | 6.19x | |
| Weighted average by Cap. | 2.12% | 2.19% | 33.03x | 89.62x | 8.16x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
